Cutis 2020
DOI: 10.12788/cutis.0014
|View full text |Cite
|
Sign up to set email alerts
|

Isobornyl Acrylate and Diabetic Devices Steal the Show for the 2020 American Contact Dermatitis Society Allergen of the Year

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 11 publications
0
10
0
Order By: Relevance
“…Irritant contact dermatitis (ICD) and ACD are common findings among patients with diabetes who use GS and CSII, 8,10–15 usually presenting as annular erythematous lesions at the sites where the device has been applied 7,10 . Compared to ACD, ICD usually has an earlier presentation of symptoms.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Irritant contact dermatitis (ICD) and ACD are common findings among patients with diabetes who use GS and CSII, 8,10–15 usually presenting as annular erythematous lesions at the sites where the device has been applied 7,10 . Compared to ACD, ICD usually has an earlier presentation of symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, patients undergo patch testing to identify the culprit of any ACD. However, this task is complicated by the fact that manufacturers do not need to disclose the chemical composition of their product 7,11 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, a worldwide epidemic has emerged of cutaneous adverse events related to the use of medical devices (MDs) worn by people with diabetes. Numerous cases have been published regarding allergic contact dermatitis (ACD) caused by acrylates present in glucose sensors and insulin pumps, not only in adults 1–3 but also in the paediatric diabetic patient population 4–6 …”
mentioning
confidence: 99%
“…In recent years, a worldwide epidemic has emerged of cutaneous adverse events related to the use of medical devices (MDs) worn by people with diabetes. Numerous cases have been published regarding allergic contact dermatitis (ACD) caused by acrylates present in glucose sensors and insulin pumps, not only in adults [1][2][3] but also in the paediatric diabetic patient population. [4][5][6] The new glucose monitoring systems and insulin pumps are innovative instruments allowing patients with diabetes to optimize glycaemic control without the burden of repeated skin pricks.…”
mentioning
confidence: 99%